To support BOPA members managing the introduction of biosimilar rituximab, a paper has been published on the members documents section of website which BOPA members can use in their own hospital to support rapid infusion of biosimilar rituximab
There is also details of an accompanying audit.
See http://www.bopawebsite.org/publications/members-documents
Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…
The British Colorectal Oncology Group warmly invites you to its inaugural annual conference at the Queen’s Hotel, Leeds Find the conference agenda here – BCOG-Annual-Conference-Programme-2026.pdf Register NOW – British Colorectal…
Participants are invited to participate in the Highlights of CAPhO Conference 2026 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO). Taking place on Wednesday, August 19, 2026 at 08:00 PT,…
Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee. Summary of nominations: In 2026 we received 9 nominations for 6…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
